ОбзорГрафикНовостиTraderScreen

BVT Discount Zert ABBN 28.06.2024/  DE000VM8R5C3  /

Frankfurt Zert./VONT
21.06.2024  20:01:50 Изменение+0.060 Бид20:01:50 Предложение20:01:50 Базовый актив Цена исполнения Дата истечения Тип опциона
42.960EUR +0.14% -
Величина цены спроса: -		 -
Величина цены предложения: -		 ABB LTD N - CHF 28.06.2024 Call
GlobeNewswire 14:05 N2OFFAnnounces Breakthrough in Reducing N₂O Emissions with Innovative Bacterial Technology in Corn C...
GlobeNewswire 14:05 Xeriant Provides Update on NEXBOARD™ Certification Process
GlobeNewswire 14:05 Tevogen Bio Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood A...
GlobeNewswire 14:00 Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual Meeting of the Society of C...
GlobeNewswire 14:00 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial
GlobeNewswire 14:00 Proscia And Nucleai Partner To Broaden Access To AI Predictive Biomarkers
GlobeNewswire 14:00 Lightbridge Welcomes Passage of the ADVANCE Act, Landmark Legislation to Expedite Commercial Deploym...
GlobeNewswire 14:00 AFCEA International Proudly Announces New Board Chair, Vice Chair, Executive Committee and Board of ...
GlobeNewswire 14:00 Stingray Delivers Popular Music and Concert Content to The Roku Channel in the US and Canada
Newsfile Corp 14:00 Teako Minerals Successfully Concludes Sandefjord Rare Earth Element Program and Mobilizes Field Crew...
Newsfile Corp 14:00 Prospective Trial Shows Impact of Home OCT Guided Wet AMD Patient Management
GlobeNewswire 14:00 LOBO EV Strengthens Partnership with a Well-Established Brazilian Distributor Following Successful O...
GlobeNewswire 14:00 Pacific Green enters Polish energy storage market with double acquisition
GlobeNewswire 14:00 Eagle Gold Mine Operations Update
GlobeNewswire 14:00 Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epine...
GlobeNewswire 14:00 Treasure Global Inc Announces New Leadership Team to Drive New Vision and Strategy Forward
GlobeNewswire 14:00 BioVie Presents Protocol Design of Upcoming SUNRISE-PD Phase 2 Trial of Bezisterim in Patients with ...
GlobeNewswire 14:00 Asset Entities Golf Consultant and Shareholder Bryson DeChambeau Wins U.S. Open
GlobeNewswire 14:00 Recce Pharmaceuticals Receives Ethics Approval to Broaden RECCE® 327 Gel Trials Across all Topical B...
GlobeNewswire 14:00 Skyharbour and JV Partner Orano Announce Completion of Geophysics and Upcoming Commencement of Field...
GlobeNewswire 14:00 Tyton Partners’ Choose to Learn 2024 Research Reveals Massive Untapped Demand for K-12 Parent Naviga...
GlobeNewswire 14:00 Tyton Partners Paying for Choice 2024 Research Finds That Education Savings Accounts (ESAs) Can Help...
GlobeNewswire 14:00 PEAK:AIO Commits to the Future of AI Healthcare; Announces the Appointment of Professor Sebastien Ou...
GlobeNewswire 14:00 BriteCore Solution Marketplace Continues Momentum
GlobeNewswire 14:00 Immutep Signs Exclusive License Agreement with Cardiff University for Next Generation Anti-LAG-3 Mol...